The results of univariate analyses revealed that age at BC onset does not play an important prognostic role in BRCA1/BRCA2 mutation carriers and indicated that age should not be considered as a factor influencing patients’ treatment approaches. This evidence concerns the gene BRCA1 and breast cancer.